机器人对比腹腔镜腹腔内补片腹壁疝修补的患者报告结局:PROVE-IT随机临床试验
IMPORTANCE: Despite rapid adoption of the robotic platform for ventral hernia repair with intraperitoneal mesh in the United States, there is no level I evidence comparing it with the traditional laparoscopic approach.…
核心结论
- 腹腔镜与机器人腹腔内补片腹壁疝修补结局相当,机器人途径增加的手术时间和成本未带来可测量的临床获益。
研究设计与样本
- 注册库基础、单盲、前瞻性随机临床试验,于2017年9月至2020年1月在克利夫兰诊所腹部核心健康中心完成,最短随访30天,由1家学术三级医院的2名外科医生实施。
主要发现
- 术后PROMIS 3a疼痛强度和疝特异性生活质量评分、住院时间及并发症率相似。
- 每组各有2例内脏损伤,但无全层肠切开或非计划再手术。
临床怎么用
- 对于预期宽度≤7 cm的中线腹壁疝择期微创修补,腹腔镜与机器人途径在疼痛、生活质量和并发症方面结局相当。
- 选择机器人途径时应权衡其更长手术时间和更高成本,不应期望可测量的临床获益。
局限性
- 随访最短30天,未报告长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Despite rapid adoption of the robotic platform for ventral hernia repair with intraperitoneal mesh in the United States, there is no level I evidence comparing it with the traditional laparoscopic approach. This randomized clinical trial sought to demonstrate a clinical benefit to the robotic approach. OBJECTIVE: To determine whether robotic approach to ventral hernia repair with intraperitoneal mesh would result in less postoperative pain. DESIGN, SETTING, AND PARTICIPANTS: A registry-based, single-blinded, prospective randomized clinical trial at the Cleveland Clinic Center for Abdominal Core Health, Cleveland, Ohio, completed between September 2017 and January 2020, with a minimum follow-up duration of 30 days. Two surgeons at 1 academic tertiary care hospital. Patients with primary or incisional midline ventral hernias of an anticipated width of 7 cm or less presenting in the elective setting and able to tolerate a minimally invasive repair. INTERVENTIONS: Patients were randomized to a standardized laparoscopic or robotic ventral hernia repair with fascial closure and intraperitoneal mesh. MAIN OUTCOMES AND MEASURES: The trial was powered to detect a 30% difference in the Numerical Rating Scale (NRS-11) on the first postoperative day. Secondary end points included the Patient-Reported Outcomes Measurement Information System Pain Intensity short form (3a), hernia-specific quality of life, operative time, wound morbidity, recurrence, length of stay, and cost. RESULTS: Seventy-five patients completed their minimally invasive hernia repair: 36 laparoscopic and 39 robotic. Baseline demographics and hernia characteristics were comparable. Robotic operations had a longer median operative time (146 vs 94 minutes; P < .001). There were 2 visceral injuries in each cohort but no full-thickness enterotomies or unplanned reoperations. There were no significant differences in NRS-11 scores preoperatively or on postoperative days 0, 1, 7, or 30. Specifically, median NRS-11 scores on the first postoperative day were the same (5 vs 5; P = .61). Likewise, postoperative Patient-Reported Outcomes Measurement Information System 3a and hernia-specific quality-of-life scores, as well as length of stay and complication rates, were similar. The robotic platform adds cost (total cost ratio, 1.13 vs 0.97; P = .03), driven by the cost of additional operating room time (1.25 vs 0.85; P < .001). CONCLUSIONS AND RELEVANCE: Laparoscopic and robotic ventral hernia repair with intraperitoneal mesh have comparable outcomes. The increased operative time and proportional cost of the robotic approach are not offset by a measurable clinical benefit. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03283982.
引用
- Petro CC, Zolin S, Krpata D, et al. Patient-Reported Outcomes of Robotic vs Laparoscopic Ventral Hernia Repair With Intraperitoneal Mesh: The PROVE-IT Randomized Clinical Trial. JAMA Surg. 2021. PMID: 33084881. doi:10.1001/jamasurg.2020.4569
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。